Quick Takeaways
- Roger M. Klein filed SCHEDULE 13D for Evoke Pharma Inc Common Stock, par value $0.0001 per share (EVOK).
- Disclosed ownership: 10%.
- Date of event: 04 Nov 2025.
Roger M. Klein - 04 Nov 2025 SCHEDULE 13D Report for Evoke Pharma Inc Common Stock, par value $0.0001 per share (EVOK)
- Filing Manager
- Roger M. Klein
- Reporting Manager
- Klein Roger M.
- Symbol
- EVOK
- Shares outstanding
- 1,552,381 shares
- Disclosed Ownership
- 163,000 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13D
- Filing time
- 12 Nov 2025, 16:41:14 UTC
- Date of event
- 04 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Roger M. Klein disclosed 10% ownership in Evoke Pharma Inc Common Stock, par value $0.0001 per share (EVOK) on 04 Nov 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 Nov 2025, 16:41.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Klein Roger M. | 10% | 163,000 | 163,000 | 0 | /s/ Roger M. Klein | Roger M. Klein | 0001651175 |
| Krieger Charitable Trust | 8.3% | 129,000 | 0 | 129,000 | /s/ Roger M. Klein | Roger M. Klein, Trustee |